Guardian Pharmacy Services, Inc. (GRDN)

GRDN Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,390	1,228	1,046	908.91	792.07	735.96
Revenue Growth (YoY)	18.68%	17.42%	15.10%	14.75%	7.63%	5.39%
Cost of Revenue	1,115	984.04	837.88	723.04	630.81	588.96
Gross Profit	274.32	244.37	208.31	185.87	161.27	147
Selling, General & Admin	212.01	302.85	143.91	133.88	118.09	102.54
Operating Expenses	212.01	302.85	143.91	133.88	131.12	114.05
Operating Income	62.31	-58.48	64.4	51.99	30.15	32.95
Interest Expense	-0.92	-3.28	-2.86	-1.93	-1.64	-2.16
Other Non Operating Income (Expenses)	0.77	-0.28	-0.37	-0.4	-0.19	-0.25
EBT Excluding Unusual Items	62.16	-62.04	61.17	49.66	28.33	30.54
Merger & Restructuring Charges	-	-	-	-	-	-0.25
Other Unusual Items	-3.62	-4.44	-23.45	-	-	-0.64
Pretax Income	58.55	-66.48	37.72	49.66	28.33	29.66
Income Tax Expense	19.01	4.56	-	-	-	-
Earnings From Continuing Operations	39.53	-71.03	37.72	49.66	28.33	29.66
Minority Interest in Earnings	0.71	-16.25	-13.82	-14.24	-12.01	-9.72
Net Income	40.24	-87.29	23.9	35.42	16.31	19.94
Preferred Dividends & Other Adjustments	22.76	22.76	23.9	-	-	-
Net Income to Common	17.48	-110.05	-	35.42	16.31	19.94
Net Income Growth	-	-	-32.52%	117.12%	-18.20%	-8.29%
Shares Outstanding (Basic)	63	62	-	-	-	-
Shares Outstanding (Diluted)	64	62	-	-	-	-
EPS (Basic)	0.28	-1.77	-	-	-	-
EPS (Diluted)	0.28	-1.77	-	-	-	-
Free Cash Flow	68.17	41.59	56.26	31.75	49.22	44.27
Free Cash Flow Per Share	1.07	0.67	-	-	-	-
Gross Margin	19.74%	19.89%	19.91%	20.45%	20.36%	19.97%
Operating Margin	4.48%	-4.76%	6.16%	5.72%	3.81%	4.48%
Profit Margin	1.26%	-8.96%	-	3.90%	2.06%	2.71%
Free Cash Flow Margin	4.91%	3.39%	5.38%	3.49%	6.21%	6.02%
EBITDA	84.06	-38.71	82.63	68.55	46.68	50.2
EBITDA Margin	6.05%	-3.15%	7.90%	7.54%	5.89%	6.82%
D&A For EBITDA	21.75	19.77	18.23	16.56	16.53	17.26
EBIT	62.31	-58.48	64.4	51.99	30.15	32.95
EBIT Margin	4.48%	-4.76%	6.16%	5.72%	3.81%	4.48%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q